346688 <common-name>4-[5,6-dichloro-2-[(e)-3-(5,6-dichloro-1,3-diethylbenzimidazol-2-ylidene)prop-1-enyl]-3-ethylbenzimidazol-1-ium-1-yl]butane-2-sulfonic acid</common-name> <description>4-[5,6-dichloro-2-[(e)-3-(5,6-dichloro-1,3-diethylbenzimidazol-2-ylidene)prop-1-enyl]-3-ethylbenzimidazol-1-ium-1-yl]butane-2-sulfonic acid is a chemical compound with the formula C27H31Cl4N4O3S+. With an average molecular weight of 633.40 g/mol, 4-[5,6-dichloro-2-[(e)-3-(5,6-dichloro-1,3-diethylbenzimidazol-2-ylidene)prop-1-enyl]-3-ethylbenzimidazol-1-ium-1-yl]butane-2-sulfonic acid is a heavy molecule.</description> <cas nil="true"/> <pubchem-id>6438178</pubchem-id> <chemical-formula>C27H31Cl4N4O3S+</chemical-formula> <weight>633.4</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T10:12:14Z</created-at> <updated-at type="dateTime">2026-08-31T10:12:14Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CCN1C2=CC(=C(C=C2[N+](=C1C=CC=C3N(C4=CC(=C(C=C4N3CC)Cl)Cl)CC)CCC(C)S(=O)(=O)O)Cl)Cl</moldb-smiles> <moldb-formula>C27H31Cl4N4O3S+</moldb-formula> <moldb-inchi>InChI=1S/C27H30Cl4N4O3S/c1-5-32-22-13-18(28)19(29)14-23(22)33(6-2)26(32)9-8-10-27-34(7-3)24-15-20(30)21(31)16-25(24)35(27)12-11-17(4)39(36,37)38/h8-10,13-17H,5-7,11-12H2,1-4H3/p+1</moldb-inchi> <moldb-inchikey>CBCXVHROZDDZRK-UHFFFAOYSA-O</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">631.087098</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>7.5</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM342581</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>4-[5,6-dichloro-2-[(e)-3-(5,6-dichloro-1,3-diethylbenzimidazol-2-ylidene)prop-1-enyl]-3-ethylbenzimidazol-1-ium-1-yl]butane-2-sulfonic acid</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Benzimidazoles</klass> <subklass nil="true"/> <paper-count type="integer" nil="true"/> <sync-id>CED0297040</sync-id> <structure-inchikey>CBCXVHROZDDZRK-UHFFFAOYSA-O</structure-inchikey> <structure-fingerprint>400000002004000000008000000000000000000000110040000000000000000000000010020000000000010200020000000000000000800000010000000000040000080000004000000c8000000000000120000400000200000001001000000000002400210000001000200000100020000000000100080008000000000000000000000040000000010140000020000000004000000000000000000000000000000100000000040000000000080000000000000000000000080000000000000000002000420000000000000000000000000110000000000000000000000000008000000000000000000040000000000000000000000000020000000020000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAnAAAAKgAAAIABBgBgAAAAAQMGAGAAAAAC AgdAKAAAAAMDBkAoAAAAAwQGQGgAAAADAwEGQCgAAAADBAZAKAAAAAMEBkBo AAAAAwMBBkAoAAAAAwQHYCoAAAABAwQGQCgAAAADBAYAaAAAAAMDAQYAaAAA AAMDAQYAaAAAAAMDAQYAKAAAAAMEBwAoAAAAAwMGQCgAAAADBAZAaAAAAAMD AQZAKAAAAAMEBkAoAAAAAwQGQGgAAAADAwEGQCgAAAADBAcAKAAAAAMDBgBg AAAAAgIGAGAAAAABAxEAIAAAAAERACAAAAABBgBgAAAAAgIGAGAAAAABAwYA YAAAAAICBgBgAAAAAgIGAGAAAAADAQYAYAAAAAEDEAAgAAAABggAKAAAAAMC CAAoAAAAAwIIAGAAAAABAREAIAAAAAERACAAAAABCwABAAECAAIDaAwDBGgM BAVoDAUGaAwGB2gMBwhoDAgJaAwJCmgMCgsgCwwoAgwNIA0OKAIODyAPECAQ EWgMERJoDBITaAwTFGgMFBVoDBUWIBYXABcYABMZABIaAA8bABscAAkdAB0e AB4fAB8gAB8hACEiCAIhIwgCISQABiUABSYACgJoDAgDaAwWDiAVEGgMQgQA AAAFAgMICQoGBAUGBwgDBQ8OFhUQBhESExQVEBcEAAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:45:21Z</structure-indexed-at> </compound>